Disc Medicine Inc. (IRON) NASDAQ

$30.63 0.11 (0.34%)

Market Cap: $736.77M

As of 04/16/24 12:08 PM EDT. Market open.

(IRON)

Disc Medicine Inc. (IRON)
NASDAQ

$30.63
0.11 (0.34%)

Market Cap: $736.77M

As of 04/16/24 12:08 PM EDT. Market open.

Add to Portfolio

disc medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis) in hematologic diseases. focused on the hepcidin pathway, the master regulator of iron metabolism, disc is advancing first-in-class therapies to transform the treatment of hematologic ... read more

disc medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis) in hematologic diseases. focused on the hepcidin pathway, the master regulator of iron metabolism, disc is advancing first-in-class therapies to transform the treatment of hematologic diseases. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
52
URL
Address
.
PRICE CHART FOR DISC MEDICINE INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$30.13
Previous Close
$30.52
Days Range
$30.42 - $32.45
52 week range
$23.30 - $77.60
Volume
88,563
Avg. Volume (30 days)
815,747
Market Cap
$736.77M
Dividend Yield
-
P/E
-
Shares Outstanding
24,140,428
Open
$30.13
Previous Close
$30.52
Days Range
$30.42 - $32.45
52 week range
$23.30 - $77.60
Volume
88,563
Avg. Volume (30 days)
815,747
Market Cap
$736.77M
Dividend Yield
-
P/E
-
Shares Outstanding
24,140,428
FINANCIAL STATEMENTS FOR DISC MEDICINE INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR DISC MEDICINE INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
White William RichardDirectorApr 11, 2024 Option Exercise$4.912,56012,5812,560Apr 15, 2024, 06:27 PM
White William RichardDirectorApr 11, 2024 Sale$31.802,56081,40778Apr 15, 2024, 06:27 PM
Savage William JacobChief Medical OfficerApr 10, 2024 Option Exercise$2.6521,87057,95643,405Apr 11, 2024, 05:02 PM
Bitterman KevinDirectorMar 05, 2024 Sale$73.5026,1571,922,540677,503Mar 07, 2024, 04:40 PM
Bitterman KevinDirectorJan 23, 2024 Sale$67.65102,5006,934,125703,660Jan 25, 2024, 04:33 PM
Atlas Venture Fund X, L.P.10% OwnerJan 23, 2024 Sale$67.65102,5006,934,125703,660Jan 25, 2024, 04:31 PM
Atlas Venture Fund X, L.P.10% OwnerJan 23, 2024 Sale$67.6547,5003,213,3751,402,186Jan 25, 2024, 04:31 PM
Bitterman KevinDirectorJan 10, 2024 Sale$64.0020,0001,280,000786,160Jan 12, 2024, 05:12 PM
Atlas Venture Fund X, L.P.10% OwnerJan 10, 2024 Sale$64.0020,0001,280,000786,160Jan 12, 2024, 05:12 PM
Atlas Venture Fund X, L.P.10% OwnerJan 10, 2024 Sale$64.0030,0001,920,0001,449,686Jan 12, 2024, 05:12 PM
Bryce JoanneChief Financial OfficerDec 27, 2023 Option Exercise$9.863,00029,5805,500Dec 29, 2023, 04:15 PM
ORBIMED ADVISORS LLCDirectorDec 18, 2023 Option Exercise$38.001,72465,5121,724Dec 20, 2023, 06:28 PM
ORBIMED ADVISORS LLCDirectorDec 18, 2023 Sale$59.241,724102,1300Dec 20, 2023, 06:28 PM
Ashiya MonaDirectorDec 18, 2023 Option Exercise$38.001,72465,5121,724Dec 20, 2023, 06:16 PM
Ashiya MonaDirectorDec 18, 2023 Sale$59.241,724102,1300Dec 20, 2023, 06:16 PM
Ashiya MonaDirectorDec 14, 2023 Sale$56.75433,20024,584,100897,625Dec 15, 2023, 06:09 PM
ORBIMED ADVISORS LLCDirectorDec 14, 2023 Sale$56.75433,20024,584,100897,625Dec 15, 2023, 06:04 PM
Bitterman KevinDirectorDec 14, 2023 Sale$58.2820,5491,197,567806,280Dec 14, 2023, 08:14 PM
Bitterman KevinDirectorDec 13, 2023 Sale$60.003,548212,865826,749Dec 14, 2023, 08:14 PM
Bitterman KevinDirectorDec 12, 2023 Sale$62.8051,9673,263,328861,401Dec 14, 2023, 08:14 PM
Atlas Venture Fund X, L.P.10% OwnerDec 14, 2023 Sale$58.2820,5491,197,567806,280Dec 14, 2023, 08:13 PM
Atlas Venture Fund X, L.P.10% OwnerDec 14, 2023 Sale$58.2830,8251,796,4371,479,866Dec 14, 2023, 08:13 PM
Atlas Venture Fund X, L.P.10% OwnerDec 13, 2023 Sale$60.003,548212,865826,749Dec 14, 2023, 08:13 PM
Atlas Venture Fund X, L.P.10% OwnerDec 13, 2023 Sale$60.005,323319,3571,510,571Dec 14, 2023, 08:13 PM
Atlas Venture Fund X, L.P.10% OwnerDec 12, 2023 Sale$62.8051,9673,263,328861,401Dec 14, 2023, 08:13 PM
Atlas Venture Fund X, L.P.10% OwnerDec 12, 2023 Sale$62.8077,9514,895,0321,562,550Dec 14, 2023, 08:13 PM
ORBIMED ADVISORS LLCDirectorDec 13, 2023 Sale$58.56106,7006,248,3521,126,225Dec 14, 2023, 05:44 PM
ORBIMED ADVISORS LLCDirectorDec 12, 2023 Sale$60.1627,3001,642,3681,182,425Dec 14, 2023, 05:44 PM
ORBIMED ADVISORS LLCDirectorDec 14, 2023 Sale$57.7320011,5461,126,125Dec 14, 2023, 05:44 PM
Ashiya MonaDirectorDec 14, 2023 Sale$57.7320011,5461,126,125Dec 14, 2023, 05:40 PM
Ashiya MonaDirectorDec 13, 2023 Sale$58.56106,7006,248,3521,126,225Dec 14, 2023, 05:40 PM
Ashiya MonaDirectorDec 12, 2023 Sale$60.1627,3001,642,3681,182,425Dec 14, 2023, 05:40 PM
White William RichardDirectorDec 12, 2023 Option Exercise$6.0833,511203,88333,511Dec 14, 2023, 04:15 PM
White William RichardDirectorDec 12, 2023 Sale$63.2133,5112,118,23921,411Dec 14, 2023, 04:15 PM
Bryce JoanneChief Financial OfficerDec 12, 2023 Option Exercise$2.652,5006,6255,000Dec 14, 2023, 04:15 PM
Bryce JoanneChief Financial OfficerDec 12, 2023 Sale$65.222,500163,0622,500Dec 14, 2023, 04:15 PM
Bryce JoanneChief Financial OfficerDec 05, 2023 Option Exercise$1.011,2811,2945,041Dec 07, 2023, 04:15 PM
Bryce JoanneChief Financial OfficerDec 05, 2023 Sale$56.002,541142,2993,893Dec 07, 2023, 04:15 PM
Khara RahulGeneral CounselNov 22, 2023 Option Exercise$14.6910,000146,90010,000Nov 27, 2023, 04:15 PM
Khara RahulGeneral CounselNov 22, 2023 Sale$51.7310,000517,3339,900Nov 27, 2023, 04:15 PM
Khara RahulGeneral CounselNov 14, 2023 Option Exercise$14.694,90071,9814,900Nov 15, 2023, 05:00 PM
Khara RahulGeneral CounselNov 14, 2023 Sale$50.614,900248,012787Nov 15, 2023, 05:00 PM
Khara RahulGeneral CounselNov 03, 2023 Option Exercise$14.691001,469100Nov 07, 2023, 06:22 PM
Khara RahulGeneral CounselNov 03, 2023 Sale$50.001005,0000Nov 07, 2023, 06:22 PM
Atlas Venture Fund X, L.P.10% OwnerSep 14, 2023 Sale$53.0594,4405,010,0421,856,794Sep 18, 2023, 04:59 PM
Atlas Venture Fund X, L.P.10% OwnerSep 16, 2023 Sale$53.222,115112,5601,593,785Sep 18, 2023, 04:59 PM
Atlas Venture Fund X, L.P.10% OwnerSep 15, 2023 Sale$53.16260,89413,869,1251,595,900Sep 18, 2023, 04:59 PM
Bryce JoanneChief Financial OfficerSep 11, 2023 Option Exercise$9.862,50024,6503,760Sep 13, 2023, 04:15 PM
Bryce JoanneChief Financial OfficerSep 01, 2023 Option Exercise$2.651,0002,6502,260Sep 05, 2023, 04:16 PM
Bryce JoanneChief Financial OfficerSep 01, 2023 Sale$52.991,00052,9901,260Sep 05, 2023, 04:16 PM
Savage William JacobChief Medical OfficerAug 21, 2023 Option Exercise$2.653,0007,9503,000Aug 22, 2023, 04:06 PM
Bitterman KevinDirectorAug 15, 2023 Sale$52.4072,9313,821,585882,224Aug 17, 2023, 04:13 PM
Atlas Venture Fund X, L.P.10% OwnerAug 15, 2023 Sale$52.4072,9313,821,585882,224Aug 16, 2023, 06:55 PM
Atlas Venture Fund X, L.P.10% OwnerAug 15, 2023 Sale$52.40111,0695,820,0161,951,234Aug 16, 2023, 06:55 PM
Atlas Venture Fund X, L.P.10% OwnerAug 14, 2023 Sale$52.59175,0009,203,6002,162,303Aug 16, 2023, 06:55 PM
Savage William JacobChief Medical OfficerAug 15, 2023 Sale$52.957,672406,2353,964Aug 16, 2023, 04:15 PM
Savage William JacobChief Medical OfficerAug 09, 2023 Sale$49.838,269412,06412,741Aug 11, 2023, 04:15 PM
Bryce JoanneChief Financial OfficerAug 01, 2023 Option Exercise$1.014,5214,5665,781Aug 03, 2023, 04:18 PM
Bryce JoanneChief Financial OfficerAug 01, 2023 Sale$49.914,521225,6332,714Aug 03, 2023, 04:18 PM
MacDonald Brian RichardChief Innovation OfficerJun 30, 2023 Sale$45.264,924222,83614,277Jun 30, 2023, 06:29 PM
MacDonald Brian RichardChief Innovation OfficerJun 29, 2023 Sale$45.795,100233,50921,564Jun 30, 2023, 06:29 PM
MacDonald Brian RichardChief Innovation OfficerJun 28, 2023 Sale$49.965,100254,79525,153Jun 30, 2023, 06:29 PM
Bryce JoanneChief Financial OfficerJun 28, 2023 Option Exercise$1.017,8807,95911,332Jun 30, 2023, 04:49 PM
Bryce JoanneChief Financial OfficerJun 28, 2023 Sale$49.9510,072503,1146,524Jun 30, 2023, 04:49 PM
Savage William JacobChief Medical OfficerJun 28, 2023 Sale$49.984,384219,11418,805Jun 30, 2023, 04:12 PM
Novo Holdings A/S10% OwnerJun 28, 2023 Sale$46.101,250,00057,624,9981,090,772Jun 28, 2023, 05:04 PM
Ashiya MonaDirectorFeb 15, 2023 Buy$23.00108,6962,500,0081,196,825Feb 17, 2023, 04:48 PM
ORBIMED ADVISORS LLCDirectorFeb 15, 2023 Buy$23.00108,6962,500,0081,196,825Feb 17, 2023, 04:43 PM
AI DMI LLC10% OwnerFeb 15, 2023 Buy$23.00434,78310,000,0093,141,759Feb 17, 2023, 04:42 PM
Leonard Braden Michael10% OwnerOct 26, 2022 Sale$2.0922,50047,025247,500Oct 27, 2022, 04:23 PM
Piekos BrianCFOMay 31, 2022 Option Exercise$1.099,96010,85617,615Jun 02, 2022, 07:14 PM
Leonard Braden Michael10% OwnerApr 12, 2022 Buy$1.42203,744290,1934,808,231Apr 13, 2022, 04:09 PM
Leonard Braden Michael10% OwnerApr 11, 2022 Buy$1.35504,487681,0574,604,487Apr 13, 2022, 04:09 PM
Leonard Braden Michael10% OwnerApr 12, 2022 Buy$1.3755,00075,075270,000Apr 13, 2022, 04:09 PM
Leonard Braden Michael10% OwnerApr 13, 2022 Buy$1.52191,769291,6045,000,000Apr 13, 2022, 04:09 PM
Tananbaum James B.DirectorFeb 05, 2021 Option Exercise$10.001,500,00015,000,0001,500,000Feb 09, 2021, 04:00 PM
FS Development Holdings, LLC10% OwnerFeb 05, 2021 Option Exercise$10.001,500,00015,000,0001,500,000Feb 09, 2021, 03:04 PM
FS Development Holdings, LLC10% OwnerAug 14, 2020 Buy$10.00441,5004,415,000441,500Oct 19, 2020, 08:49 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
White William RichardDirector04/11/202412,581
White William RichardDirector04/11/202481,407
Savage William JacobChief Medical Officer04/10/202457,956
Bitterman KevinDirector03/05/20241,922,540
Bitterman KevinDirector01/23/20246,934,125
Atlas Venture Fund X, L.P.10% Owner01/23/20246,934,125
Atlas Venture Fund X, L.P.10% Owner01/23/20243,213,375
Bitterman KevinDirector01/10/20241,280,000
Atlas Venture Fund X, L.P.10% Owner01/10/20241,280,000
Atlas Venture Fund X, L.P.10% Owner01/10/20241,920,000
Bryce JoanneChief Financial Officer12/27/202329,580
ORBIMED ADVISORS LLCDirector12/18/202365,512
ORBIMED ADVISORS LLCDirector12/18/2023102,130
Ashiya MonaDirector12/18/202365,512
Ashiya MonaDirector12/18/2023102,130
Ashiya MonaDirector12/14/202324,584,100
ORBIMED ADVISORS LLCDirector12/14/202324,584,100
Bitterman KevinDirector12/14/20231,197,567
Bitterman KevinDirector12/13/2023212,865
Bitterman KevinDirector12/12/20233,263,328
Atlas Venture Fund X, L.P.10% Owner12/14/20231,197,567
Atlas Venture Fund X, L.P.10% Owner12/14/20231,796,437
Atlas Venture Fund X, L.P.10% Owner12/13/2023212,865
Atlas Venture Fund X, L.P.10% Owner12/13/2023319,357
Atlas Venture Fund X, L.P.10% Owner12/12/20233,263,328
Atlas Venture Fund X, L.P.10% Owner12/12/20234,895,032
ORBIMED ADVISORS LLCDirector12/13/20236,248,352
ORBIMED ADVISORS LLCDirector12/12/20231,642,368
ORBIMED ADVISORS LLCDirector12/14/202311,546
Ashiya MonaDirector12/14/202311,546
Ashiya MonaDirector12/13/20236,248,352
Ashiya MonaDirector12/12/20231,642,368
White William RichardDirector12/12/2023203,883
White William RichardDirector12/12/20232,118,239
Bryce JoanneChief Financial Officer12/12/20236,625
Bryce JoanneChief Financial Officer12/12/2023163,062
Bryce JoanneChief Financial Officer12/05/20231,294
Bryce JoanneChief Financial Officer12/05/2023142,299
Khara RahulGeneral Counsel11/22/2023146,900
Khara RahulGeneral Counsel11/22/2023517,333
Khara RahulGeneral Counsel11/14/202371,981
Khara RahulGeneral Counsel11/14/2023248,012
Khara RahulGeneral Counsel11/03/20231,469
Khara RahulGeneral Counsel11/03/20235,000
Atlas Venture Fund X, L.P.10% Owner09/14/20235,010,042
Atlas Venture Fund X, L.P.10% Owner09/16/2023112,560
Atlas Venture Fund X, L.P.10% Owner09/15/202313,869,125
Bryce JoanneChief Financial Officer09/11/202324,650
Bryce JoanneChief Financial Officer09/01/20232,650
Bryce JoanneChief Financial Officer09/01/202352,990
Savage William JacobChief Medical Officer08/21/20237,950
Bitterman KevinDirector08/15/20233,821,585
Atlas Venture Fund X, L.P.10% Owner08/15/20233,821,585
Atlas Venture Fund X, L.P.10% Owner08/15/20235,820,016
Atlas Venture Fund X, L.P.10% Owner08/14/20239,203,600
Savage William JacobChief Medical Officer08/15/2023406,235
Savage William JacobChief Medical Officer08/09/2023412,064
Bryce JoanneChief Financial Officer08/01/20234,566
Bryce JoanneChief Financial Officer08/01/2023225,633
MacDonald Brian RichardChief Innovation Officer06/30/2023222,836
MacDonald Brian RichardChief Innovation Officer06/29/2023233,509
MacDonald Brian RichardChief Innovation Officer06/28/2023254,795
Bryce JoanneChief Financial Officer06/28/20237,959
Bryce JoanneChief Financial Officer06/28/2023503,114
Savage William JacobChief Medical Officer06/28/2023219,114
Novo Holdings A/S10% Owner06/28/202357,624,998
Ashiya MonaDirector02/15/20232,500,008
ORBIMED ADVISORS LLCDirector02/15/20232,500,008
AI DMI LLC10% Owner02/15/202310,000,009
Leonard Braden Michael10% Owner10/26/202247,025
Piekos BrianCFO05/31/202210,856
Leonard Braden Michael10% Owner04/12/2022290,193
Leonard Braden Michael10% Owner04/11/2022681,057
Leonard Braden Michael10% Owner04/12/202275,075
Leonard Braden Michael10% Owner04/13/2022291,604
Tananbaum James B.Director02/05/202115,000,000
FS Development Holdings, LLC10% Owner02/05/202115,000,000
FS Development Holdings, LLC10% Owner08/14/20204,415,000
Load More Insider Transactions
FUNDS WITH A POSITION IN DISC MEDICINE INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ORBIMED ADVISORS LLC1,702,2371.96%-25%Other
BLACKROCK INC.868,4400.00128%34.78%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.750,0000.09%-42.68%Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)464,2920.5%7.97%Other
GEODE CAPITAL MANAGEMENT, LLC229,4190.00139%7.01%Other
CANDRIAM S.C.A.80,0000.03%NewOther
RENAISSANCE TECHNOLOGIES LLC48,2800.00432%62.61%Other
ALPS ADVISORS INC16,1500.00733%-4.44%Other
UBS OCONNOR LLC9,3380.04%-59.61%Value
CHANGE IN SHARES OUTSTANDING FOR DISC MEDICINE INC
STOCK BUYBACKS FOR DISC MEDICINE INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.54%
1Q
12/31/2023
06/30/2023
13.79%
2Q
12/31/2023
03/31/2023
28.98%
3Q

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.54%
1Q
06/30/2023
13.79%
2Q
03/31/2023
28.98%
3Q
BUYBACK ANNOUNCEMENT(S) FOR DISC MEDICINE INC
LOADING...